UPDATE 1-Lilly migraine treatment meets main goal in late-stage studies
May 12, 2017 at 07:18 AM EDT
May 12 (Reuters) - Eli Lilly and Co said on Friday its experimental treatment met the main goal of reducing the number of monthly migraine headache days compared to a placebo in three late-stage studies.
